FDA — authorised 21 December 2000
- Application: NDA050756
- Marketing authorisation holder: BAUSCH
- Local brand name: BENZACLIN
- Indication: GEL — TOPICAL
- Status: approved
🇺🇸 BenzaClin in United States
FDA authorised BenzaClin on 21 December 2000
Marketing authorisation
Frequently asked questions
Is BenzaClin approved in United States?
Yes. FDA authorised it on 21 December 2000.
Who is the marketing authorisation holder for BenzaClin in United States?
BAUSCH holds the US marketing authorisation.